BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

506365

CHEMOPH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CHEMO PHARMA LABORATORIES LTD. Share Price Update

As of the latest trading session, CHEMO PHARMA LABORATORIES LTD. share price is currently at ₹ 125.85, which is up by ₹ 5.94 from its previous closing. Today, the stock has fluctuated between ₹ 125.00 and ₹ 129.50. Over the past year, CHEMO PHARMA LABORATORIES LTD. has achieved a return of 71.70 %. In the last month alone, the return has been -0.74 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CHEMO PHARMA LABORATORIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    18.80

  • P/E Ratio (TTM)

    -1.54

  • Beta

    0.78

  • Book Value / share

    87.63

  • Return on equity

    3.47%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -11.81

info icon alternate text

CHEMO PHARMA LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 11.83
Net Profit -11.81
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -78.70
EBITDA -11.81
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.26
EBITDA -0.18
Effective Tax Rate (%) -88.88
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.17
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.17
EBITDA -0.17
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit 0.61
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 4.07
EBITDA 0.61
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.64
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.12
Net Profit 0.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.28
EBITDA 0.51
Effective Tax Rate (%) 32.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 1.20
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 8.00
EBITDA 1.65
Effective Tax Rate (%) 26.82
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.22
Net Profit 0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.32
EBITDA 0.08
Effective Tax Rate (%) 42.85
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.42
Net Profit 0.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.73
EBITDA 0.38
Effective Tax Rate (%) -55.55
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.36
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.67
EBITDA 0.33
Effective Tax Rate (%) 19.35
Particulars MAR 2016 (Values in Cr)
Book Value / Share 24.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 87.63
ROE % 3.47
ROCE % 5.24
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.35
ROE % 9.84
ROCE % 13.44
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 77.35
ROE % 0.43
ROCE % 0.78
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 77.03
ROE % 3.37
ROCE % 1.33
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.30
ROE % 2.30
ROCE % 2.85
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 3.86
Total Liabilities 3.86
Total Equity 3.67
Share Outstanding 1500000
Price to Book Ratio 0.50
Return on Assets (%) -37.44
Return on Capital (%) -39.44
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 10.62
Total Assets 13.34
Total Liabilities 13.34
Total Equity 13.14
Share Outstanding 1500000
Price to Book Ratio 1.42
Return on Assets (%) 2.56
Return on Capital (%) 2.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.10
Total Assets 13.01
Total Liabilities 13.01
Total Equity 12.80
Share Outstanding 1500000
Price to Book Ratio 0.76
Return on Assets (%) 9.22
Return on Capital (%) 9.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 11.62
Total Liabilities 11.62
Total Equity 11.60
Share Outstanding 1500000
Price to Book Ratio 0.52
Return on Assets (%) 0.40
Return on Capital (%) 0.41
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.18
Total Assets 11.66
Total Liabilities 11.66
Total Equity 11.55
Share Outstanding 1500000
Price to Book Ratio 0.54
Return on Assets (%) 4.80
Return on Capital (%) 4.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.87
Total Assets 11.05
Total Liabilities 11.05
Total Equity 10.99
Share Outstanding 1500000
Price to Book Ratio 0.24
Return on Assets (%) 2.26
Return on Capital (%) 2.27
Particulars MAR 2016 (Values in Cr)
Net Income -1.34
Cash from Operations -2.01
Cash from Investing 2.15
Cash from Financing 0.00
Net change in Cash 0.06
Free Cash Flow -2.01
Particulars MAR 2025 (Values in Cr)
Net Income 0.49
Cash from Operations -0.08
Cash from Investing 10.45
Cash from Financing -0.15
Net change in Cash 10.01
Free Cash Flow -0.08
Particulars MAR 2024 (Values in Cr)
Net Income 1.64
Cash from Operations 0.89
Cash from Investing -0.52
Cash from Financing -0.14
Net change in Cash 0.04
Free Cash Flow 0.89
Particulars MAR 2023 (Values in Cr)
Net Income 0.07
Cash from Operations -0.67
Cash from Investing 0.62
Cash from Financing -0.07
Net change in Cash -0.13
Free Cash Flow -0.67
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations -0.26
Cash from Investing 0.96
Cash from Financing -2.12
Net change in Cash -1.48
Free Cash Flow -0.26
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations -0.32
Cash from Investing -0.18
Cash from Financing 1.95
Net change in Cash 1.36
Free Cash Flow -0.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.04 13.08 1.75 245.53 30.00 / 68.00
BLISS GVS PHARMA LTD 155.85 15.45 1.56 1646.55 105.05 / 190.65
CIPLA LTD 1639.30 24.56 4.24 132417.03 1310.05 / 1647.00
FERMENTA BIOTECH LIMITED 269.40 7.59 2.18 792.87 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2745.55 49.12 23.83 46511.27 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.98 17.38 5.05 245.07 30.00 / 68.00
AMRUTAJAN HEALTH LTD 719.25 38.14 6.36 2079.40 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9160.95 108.30 29.72 22902.38 6222.35 / 10653.05
BLISS GVS PHARMA LTD 152.20 22.78 1.51 1607.98 105.05 / 190.65

CHEMO PHARMA LABORATORIES LTD. shareholding pattern

Holding

Others
71.74%
Promoter Holdings
27.88%
FII
0.0%
DII
0.36%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Citric India Ltd 369500.0 (24.63%) Shareholding of Promoter and Promoter Group
Kshemtech Media Private Limited 54500.0 (3.63%) Public Shareholding
Shanta Somani 48781.0 (3.25%) Shareholding of Promoter and Promoter Group
Ravindra Somani 47411.0 (3.16%) Public Shareholding
Sudhir Harilal Kale 35000.0 (2.33%) Public Shareholding
Sudhanshu Kanda 19167.0 (1.28%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

CHEMO PHARMA LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
125.00 4.25 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 122.70
  • 26 Days 122.90
  • 10 Days 123.10
  • 50 Days 123.30
  • 12 Days 123.10
  • 100 Days 122.10
  • 20 Days 122.90
  • 200 Days 114.50
122.67 PIVOT

First Support

121.33

First Resistance

125.33

Second Support

118.67

Second Resistance

126.67

Third Support

117.33

Third Resistance

129.33

RSI

47.51

ADX

22.19

MACD

0.17

Williams % R

-73.49

Commodity Channel Index (CCI)

31.04

Date

2025-10-20

Week

62.00

Same Day

122.00

Month

470.00

1 Year

0.79

3 Year

0.43

Over 1 Month

-0.74%

down

Over 1 Year

71.70%

down

Over 3 Months

-5.40%

down

Over 3 Years

38.17%

down

Over 6 Months

-10.55%

down

Over 5 Years

42.85%

down

CHEMO PHARMA LABORATORIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

CHEMO PHARMA LABORATORIES LTD. Share Price

Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.

Parent organization Indian Private
NSE symbol [-]
Founded 1942
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Chemo Pharma Laboratories Ltd?

Answer Field

Chemo Pharma Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 125.00 as on Oct 21 2025 02:44 PM.

What is the Market Cap of Chemo Pharma Laboratories Ltd Share?

Answer Field

The market cap of Chemo Pharma Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 18.80 as on Oct 21 2025 02:44 PM.

What is the 52 Week High and Low of Chemo Pharma Laboratories Ltd?

Answer Field

The 52 Week High and Low of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 154.00 and ₹ 63.05.

What is 1 year return for Chemo Pharma Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 71.70%.

What is the P/E Ratio of Chemo Pharma Laboratories Ltd Share?

Answer Field

As on Oct 21 2025 02:44 PM the price-to-earnings (PE) ratio for Chemo Pharma Laboratories Ltd share is -1.54.

What is the PB ratio of Chemo Pharma Laboratories Ltd Share?

Answer Field

As on Oct 21 2025 02:44 PM, the price-to-book (PB) ratio for Chemo Pharma Laboratories Ltd share is 87.63.

How to Buy Chemo Pharma Laboratories Ltd Share?

Answer Field

You can trade in Chemo Pharma Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Chemo Pharma Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Chemo Pharma Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Chemo Pharma Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59